Pablo Aschner

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes

Pablo Aschner, Mark Kipnes, Jared Lunceford et al. · Diabetes Care · 2006 · 881 citations

Medicine, Pharmacology, Pharmacotherapy +17

ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents

Elizabeth J. Mayer‐Davis, Anna R. Kahkoska, Craig Jefferies et al. · Pediatric Diabetes · 2018 · 695 citations · Full text

Medicine, Endocrinology, Pediatrics +12

Multifaceted Determinants for Achieving Glycemic Control

Juliana C.N. Chan, Juan José Gagliardino, Sei Hyun Baik et al. · Diabetes Care · 2008 · 293 citations · Full text

Medicine, Health Sciences, Diabetology +13

Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study)

Julie‐Anne Nazare, Jessica Smith, Anne‐Laure Borel et al. · The American Journal of Cardiology · 2014 · 174 citations

Medicine, Endocrinology, Epidemiology +11

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Pablo Aschner, H. L. Katzeff, Hongquan Guo et al. · Diabetes Obesity and Metabolism · 2009 · 156 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15